Quantum-Si is sponsoring and moderating the panel event "Breaking Boundaries: How Next-Generation Protein Sequencing™ is ...

The next-generation sequencing market valued at US$ 13.92 billion in 2023, is forecasted to grow at a robust CAGR of 11.0%, reaching US$ ...

基因拷贝数变异（ gene CNV ）是种群适应性进化的主要遗传基础之一，但传统检测种群间基因CNV分化方法存在不少难题。二代测序技术虽然成本较低，但其传统检测手段在面对 CNV 时，容易受到 GC 含量偏差、重复序列以及低测序深度的影响，通常需要进行较深的测序，在样本较多情况下无疑增加了成本。而三代测序技术虽然在 CNV 检测的准确度上表现较好，但费用相对较高。

Next-generation sequencing, proteomics analysis, and circulating tumor DNA demonstrate how precision medicine advances ...

Published in Cell Reports Medicine, results of a VHIO-led study support the feasibility of using RAD51 testing to complement ...

The webinar series titled "The Basics of Next Generation Sequencing and its Application in Precision Oncology" aims to provide a comprehensive understanding of the fundamentals and practical ...

AI-based early warning and wildlife movement tracking systems are helping in mitigating the man-animal conflict in areas where there has been a significant surge in such instances in recent years ...

Results of a study led by the Vall d'Hebron Institute of Oncology (VHIO) support the feasibility of using RAD51 testing to ...

Si Incorporated (Nasdaq: QSI) ("Quantum-Si," "QSI" or the "Company"), The Protein Sequencing Company ™, announces the ...